| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |